Global Nucleic Acid Isolation and Purification Market is valued at approximately USD 4.92 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 9.24% over the forecast period 2024-2032. Nucleic acid isolation and purification involve extracting DNA and RNA from biological samples, such as cells, tissues, or fluids, and refining them for analysis. This process includes cell lysis to release nucleic acids, removal of contaminants, isolation of target nucleic acids, purification to enhance quality, and quantification for accurate analysis. These methods are essential for studying genetic information, diagnosing illnesses, and creating remedies in the fields of molecular biology, diagnostics, and therapeutics. Purified nucleic acids are essential components of PCR, sequencing, cloning, and gene editing processes, which propel technological and medical progress. The surge in demand for genetically modified crops and organisms, growing public-private funding for biotechnology and life science research, coupled with the rising inclination towards personalized medicine are the most prominent factors that are propelling the market growth across the globe.

In addition, the rise in the incidence of cancer, genetic disorders, and infectious diseases is further contributing to the demand for nucleic acid isolation and purification at a substantial rate. These tools are crucial for diagnosing cancer-specific mutations, identifying genetic disorders, and detecting pathogens responsible for infectious diseases. A rapid spread of infectious diseases, as evidenced by a World Health Organization survey conducted from January 24 to February 6, 2022, recorded around 12,368 cases of influenza viruses. Also, according to the World Health Organization, in 2020, it was estimated that nearly 19.3 million new cases of cancer were recorded globally, which is projected to rise and is likely to reach 30.2 million new cases by 2040. Nucleic acid isolation and purification technologies support personalized treatment strategies, genetic counselling, and early disease detection by enabling the extraction and analysis of nucleic acids from clinical samples, which is accelerating the market growth globally. Moreover, the rise in advancements in NGS technologies, as well as the growing emphasis on research and development activities presents various lucrative opportunities over the forecasting years. However, the high cost of automated instruments and the emergence of alternative technologies are hindering the market growth throughout the forecast period of 2024-2032.

The key regions considered for the Global Nucleic Acid Isolation and Purification (NAIP) Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of numerous market players and an increase in strategic initiatives by industry players. Also, the rise in government support and a favourable regulatory environment, alongside sustained R&D initiatives are anticipated to fuel market expansion across North America. Furthermore, the U.S. benefits from the local presence of key industry players like Thermo Fisher Scientific, Inc. and Agilent Technologies, driving technological advancements in the market. These companies are actively developing automated nucleic acid purification systems tailored for downstream applications, including next-generation sequencing and real-time PCR. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. Countries like China, India, and Japan are poised for significant market expansion due to their large populations, rising health awareness, improved incomes, and robust government initiatives bolstering the pharmaceutical sector. These factors collectively propel the growth of the NAIP market in the region. Also, the rapid rise in the scientific base, expanding pharmaceutical market, and robust manufacturing capabilities, coupled with a sizable patient pool across various countries are significantly propelling the market demand across the region. Ongoing developments, private-public collaborations, and supportive government initiatives further contribute to the region's exponential growth.

Major market players included in this report are:
QIAGEN
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Danaher
F. Hoffmann-La Roche Ltd.
Merck KGaA
Agilent Technologies
Bio-Rad Laboratories, Inc.
Takara Bio Inc.
Promega Corporation
Recent Developments in the Market:
In December 2023, Thermo Fisher Scientific Inc. unveiled the Thermo Scientific KingFisher Apex Dx, an automated nucleic acid purification instrument, along with the Applied Biosystems MagMAX Dx Pathogen/Viral NA Isolation Kit. These innovations are designed to isolate and purify bacterial and viral pathogens from biological samples.
In November 2023, LGC Biosearch Technologies announced the acquisition of PolyDesign, a company specializing in the production of solid support embedded frits utilized in DNA/RNA oligonucleotide synthesis and purification. The distinctive frit technology seamlessly integrates with LGC's Nucleic Acid Chemistry product catalogue.
In August 2023, CD Bioparticles introduced a novel series of DNA Extraction and Purification Kits tailored for dependable and swift isolation of DNA types, encompassing plasmid DNA, genomic DNA, cell-free DNA (cfDNA), mitochondrial DNA, tissue DNA, and PCR products.
In July 2023, INOVIQ Limited and Promega Corporation declared a global collaborative marketing agreement aimed at promoting Promega's Nucleic Acid purification systems and EXO-NET exosome capture technology.
In February 2023, Agilent Technologies, Inc. announced its partnership with Fluor Corporation's Advanced Technologies & Life Sciences business to enhance its oligonucleotide therapeutics manufacturing facility in Colorado. This facility will cater to the synthesis, lyophilization, and purification of custom nucleic acid therapeutics. this strategic partnership is expected to drive growth, innovation, and competitiveness within the Nucleic Acid Isolation and Purification Market, with a particular focus on advancing technologies and meeting increasing demand for high-quality nucleic acid therapeutics. This strategic partnership is expected to drive growth, innovation, and competitiveness within the Nucleic Acid Isolation and Purification Market, with a particular focus on advancing technologies and meeting increasing demand for high-quality nucleic acid therapeutics.
Global Nucleic Acid Isolation and Purification Market Report Scope:
Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2024-2032
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Type, Method, Application, End-use, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Kits & Reagents
Instruments
By Type:
DNA Isolation & Purification
RNA Isolation & Purification
By Method:
Column based
Magnetic Beads
Reagent based
Others
By Application:
Precision Medicine
Diagnostics
Drug Discovery & Development
Agriculture and Animal Research
Other Applications
By End-use:
Academic Research Institutes
Diagnostic Laboratories
Contract Research Organizations
Hospitals and Diagnostic Centers
Other End-use
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa